Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 984 products on this category.

Product data	Purity	Price range	Estimated delivery
Abiraterone Impurity 6 REF: 4Z-A-8239	- - -	To inquire	Thu 19 Dec 24
Abiraterone Proprionate REF: 4Z-A-8254CAS: 1620323-43-4	- - -	To inquire	Thu 19 Dec 24
Gimeracil Impurity 11 REF: 4Z-G-047013	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 61 REF: 4Z-E-068076	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 54 HCl REF: 4Z-C-121057CAS: 70691-56-4	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 71 REF: 4Z-P-196078	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 54 REF: 4Z-N-066072CAS: 954239-49-7	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 85 REF: 4Z-N-066098	- - -	To inquire	Thu 19 Dec 24
Bestatin-d5 (Ubenimex-d5) REF: 4Z-B-119002CAS: 58970-76-6	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 59 REF: 4Z-P-196066	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 67 REF: 4Z-P-196074	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 22 REF: 4Z-E-068035	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 60 REF: 4Z-N-066078	- - -	To inquire	Thu 19 Dec 24
Lenvatinib Impurity 25 REF: 4Z-L-124030	- - -	To inquire	Thu 19 Dec 24
N-Desmethyl Nintedanib REF: 4Z-N-066061CAS: 334951-61-0	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 33 REF: 4Z-E-068046CAS: 1705583-65-8	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 58 REF: 4Z-O-032063CAS: 24964-64-5	- - -	To inquire	Thu 19 Dec 24
Tamoxifen-d6 REF: 4Z-T-0124	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 91 REF: 4Z-N-066104	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 29 REF: 4Z-N-066046	- - -	To inquire	Thu 19 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Abiraterone Impurity 6

Ref: 4Z-A-8239

Abiraterone Proprionate

Ref: 4Z-A-8254

Gimeracil Impurity 11

Ref: 4Z-G-047013

Enzalutamide Impurity 61

Ref: 4Z-E-068076

Carfilzomib Impurity 54 HCl

Ref: 4Z-C-121057

Palbociclib Impurity 71

Ref: 4Z-P-196078

Nintedanib Impurity 54

Ref: 4Z-N-066072

Nintedanib Impurity 85

Ref: 4Z-N-066098

Bestatin-d5 (Ubenimex-d5)

Ref: 4Z-B-119002

Palbociclib Impurity 59

Ref: 4Z-P-196066

Palbociclib Impurity 67

Ref: 4Z-P-196074

Enzalutamide Impurity 22

Ref: 4Z-E-068035

Nintedanib Impurity 60

Ref: 4Z-N-066078

Lenvatinib Impurity 25

Ref: 4Z-L-124030

N-Desmethyl Nintedanib

Ref: 4Z-N-066061

Enzalutamide Impurity 33

Ref: 4Z-E-068046

Olaparib Impurity 58

Ref: 4Z-O-032063

Tamoxifen-d6

Ref: 4Z-T-0124

Nintedanib Impurity 91

Ref: 4Z-N-066104

Nintedanib Impurity 29

Ref: 4Z-N-066046